767 — Zhong Ji Longevity Science Cashflow Statement
0.000.00%
Last trade - 00:00- HK$311.96m
- HK$320.66m
- HK$161.76m
Annual cashflow statement for Zhong Ji Longevity Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 6.96 | 9.32 | 4.75 | -33.2 | — |
| Depreciation | |||||
| Non-Cash Items | -0.629 | 31.3 | -23.5 | -7.41 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -51.9 | -32.8 | 27.1 | -27.3 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -41.2 | 12 | 15.7 | -61.1 | — |
| Capital Expenditures | -0.889 | -1.03 | 0 | -0.708 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.39 | 17.6 | 0.382 | 12.2 | — |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.5 | 16.6 | 0.382 | 11.5 | — |
| Financing Cash Flow Items | 6.93 | -6.93 | -0.606 | -0.536 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.44 | -7.45 | 6.02 | 15.2 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.4 | 40.6 | 21 | -33.2 | — |